We Are Dedicated To Improving The Patient Experience Through Novel Innovation
Ashlyn Sanders, CEO & Founder
In 2014, Ashlyn was diagnosed with a rare and life-threatening neurologic condition called a Chiari Malformation, that led to emergent brain surgery and causes seizures. There is no cure for Chiari Malformations. Ashlyn started the company based on her desire to improve the patient experience for millions of others living with seizures.
Ashlyn is a graduate of UNC-Chapel Hill (B.A. Mathematics) and Duke University (M.A. Bioethics and Science Policy). She is also a former 2014 Spring White House Intern during the Obama Administration in The Office of Science and Technology Policy and The Office of Public Engagement. She is passionate about health and health policy and is very active in her community. Ashlyn is currently a 3rd year medical student at Wake Forest University School of Medicine and plans to pursue pediatric neurology.
Dr. Rhonda Gabr, MD, PhD
Neurologist, Clinical Advisor
Dr. Kimberly Garko, PhD
Senior VP of Quality at Akebia Therapeutics, Business Advisor
Dr. Loren Robinson, MD, MSHP
Chief Medical Officer & VP for Medical Affairs at Christus St. Michael Health System, Clinical Advisor
Sam Searcy
Chief Commercial Officer at Elixia Health, Senior Business Advisor
Sheila Mikhail JD, MBA
Former Co-Founder & CEO Asklepios BioPharmaceutical, Inc.
Senior Business Advisor
Kathy Meserve
Senior Director of Investments & Emerging Company Development at NC Biotech Center, Business Advisor
Gilero is a contract design, development, and manufacturing firm servicing medical device and drug-delivery device companies. From concept to commercialization, Gilero is a highly sought-after partner for any size project in the MedTech and Pharmaceutical space.
